AbbVie Options Trading: A Deep Dive into Market Sentiment - AbbVie (NYSE:ABBV)

Whales with a lot of money to spend have taken a noticeably bullish stance on AbbVie.

Looking at options history for AbbVie (NYSE:ABBV) we detected 29 trades.

If we consider the specifics of each trade, it is accurate to state that 51% of the investors opened trades with bullish expectations and 41% with bearish.

From the overall spotted trades, 11 are puts, for a total amount of $663,216 and 18, calls, for a total amount of $842,315.

Predicted Price Range

After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $120.0 and $230.0 for AbbVie, spanning the last three months.

Analyzing Volume & Open Interest

Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for AbbVie's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of AbbVie's whale trades within a strike price range from $120.0 to $230.0 in the last 30 days.

AbbVie Option Activity Analysis: Last 30 Days

Biggest Options Spotted:

Symbol	PUT/CALL	Trade Type	Sentiment	Exp. Date	Ask	Bid	Price	Strike Price	Total Trade Price	Open Interest	Volume
ABBV	CALL	SWEEP	BULLISH	03/20/26	$14.7	$13.65	$14.7	$230.00	$132.3K	42	90
ABBV	PUT	SWEEP	BULLISH	06/20/25	$1.68	$1.67	$1.67	$180.00	$131.0K	1.9K	787
ABBV	CALL	TRADE	BEARISH	04/17/25	$17.3	$17.1	$17.1	$200.00	$100.8K	1.5K	82
ABBV	PUT	TRADE	BEARISH	04/17/25	$4.9	$4.85	$4.9	$210.00	$90.1K	1.4K	588
ABBV	CALL	TRADE	BULLISH	03/21/25	$44.0	$43.45	$44.0	$170.00	$88.0K	714	0

About AbbVie

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics (including Botox).

After a thorough review of the options trading surrounding AbbVie, we move to examine the company in more detail. This includes an assessment of its current market status and performance.

Where Is AbbVie Standing Right Now?

With a trading volume of 4,371,420, the price of ABBV is up by 1.64%, reaching $214.2.
Current RSI values indicate that the stock is may be overbought.
Next earnings report is scheduled for 49 days from now.

Professional Analyst Ratings for AbbVie

2 market experts have recently issued ratings for this stock, with a consensus target price of $231.5.

Unusual Options Activity Detected: Smart Money on the Move

Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. Click here for access. * Consistent in their evaluation, an analyst from B of A Securities keeps a Neutral rating on AbbVie with a target price of $223. * Maintaining their stance, an analyst from Wells Fargo continues to hold a Overweight rating for AbbVie, targeting a price of $240.

Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for AbbVie with Benzinga Pro for real-time alerts.

ABBVAbbVie Inc

$214.50-%

Overview

Market News and Data brought to you by Benzinga APIs

To add Benzinga News as your preferred source on Google, click here.